1999
DOI: 10.1517/14656566.1.1.31
|View full text |Cite
|
Sign up to set email alerts
|

Current management of tuberculosis

Abstract: Current chemotherapeutic regimens against tuberculosis give excellent cure rates and low relapse rates if implemented and monitored correctly. This is fortunate since only two new drugs have been approved for use in this condition in the last 30 years. However, shortcomings in management and in patient compliance have resulted in an increasing prevalence of drug-resistant organisms. The global decline in the disease has been reversed due to a combination of factors including the HIV epidemic, ageing population… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2012
2012
2012
2012

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 48 publications
0
2
0
Order By: Relevance
“…Nonetheless, the clinical effectiveness of completion of treatment is well established [1], therefore it is logical that an intervention which improves implementation should also improve outcomes.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Nonetheless, the clinical effectiveness of completion of treatment is well established [1], therefore it is logical that an intervention which improves implementation should also improve outcomes.…”
Section: Discussionmentioning
confidence: 99%
“…The treatment of tuberculosis (TB) requires patients to take multiple antibiotics for a minimum of six months; if medication is taken correctly and completely, success rates for both active and latent TB approach 100% [1]. Failure to complete treatment increases the likelihood of recurrence and of developing drug resistant TB, which requires longer, more expensive, and less effective treatment [2], [3].…”
Section: Introductionmentioning
confidence: 99%